XRTX · XORTX Therapeutics Inc.
$2.06
+0.01 (+0.49%)
At close · Jul 29
Market Cap
$26.63M
Shares
12.99M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-29 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-12 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-05-19 | 2026-03-31 | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-08 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-04-16 | 2026-04-13 | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-03-27 | 2026-03-26 | |
| 6-K | 2026-03-27 | 2026-03-26 | |
| 6-K | 2026-03-27 | 2026-03-26 | |
| 6-K | 2026-03-26 | 2026-03-25 | |
| 6-K | 2026-03-24 | — | |
| 20-F | 2026-03-20 | 2025-12-31 | |
| 6-K | 2026-03-19 | 2026-03-18 | |
| 6-K | 2026-03-13 | — | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-02-27 | 2025-12-31 | |
| 6-K | 2026-02-05 | 2026-02-04 | |
| 6-K | 2026-01-02 | 2025-12-31 | |
| 6-K | 2025-11-17 | 2025-09-30 | |
| 6-K | 2025-10-31 | — | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-23 | 2025-10-22 | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-21 | 2025-10-20 | |
| 6-K | 2025-10-21 | 2025-10-20 | |
| 6-K | 2025-10-17 | — | |
| 6-K | 2025-10-17 | — | |
| 6-K | 2025-09-04 | — | |
| 6-K | 2025-09-03 | — | |
| 6-K | 2025-08-15 | 2025-06-30 | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-06-26 | — | |
| 6-K | 2025-05-19 | — | |
| 6-K | 2025-05-16 | 2025-03-31 | |
| 20-F | 2025-05-12 | 2024-12-31 | |
| 6-K | 2025-04-30 | — | |
| 6-K | 2025-04-28 | — | |
| 6-K | 2025-04-18 | 2025-04-17 | |
| 6-K | 2025-04-01 | 2025-03-31 | |
| 6-K | 2025-03-26 | 2024-12-31 | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2025-02-24 | — | |
| 6-K | 2025-01-29 | — | |
| 6-K | 2025-01-22 | 2025-01-21 | |
| 6-K | 2025-01-21 | 2025-01-17 |
Showing 1–50 of 176 filings